Latest Insider Transactions at Horizon Therapeutics Public LTD CO (HZNP)
This section provides a real-time view of insider transactions for Horizon Therapeutics Public LTD CO (HZNP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Horizon Therapeutics Public Ltd Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Horizon Therapeutics Public Ltd Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
1,099
-1.26%
|
$100,009
$91.83 P/Share
|
|
Feb 24
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
15,944
-8.01%
|
$1,450,904
$91.1 P/Share
|
|
Feb 22
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Open market or private sale
|
Direct |
5,698
-3.28%
|
$495,726
$87.81 P/Share
|
|
Feb 22
2021
|
Vikram Karnani EVP & President, International |
SELL
Open market or private sale
|
Direct |
8,358
-3.74%
|
$727,146
$87.76 P/Share
|
|
Feb 21
2021
|
Daniel A. Camardo EVP and President, U.S. |
SELL
Payment of exercise price or tax liability
|
Direct |
576
-1.24%
|
$50,688
$88.87 P/Share
|
|
Feb 21
2021
|
Daniel A. Camardo EVP and President, U.S. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+2.73%
|
-
|
|
Feb 21
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,082
-1.04%
|
$95,216
$88.87 P/Share
|
|
Feb 21
2021
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
2,182
+2.05%
|
-
|
|
Feb 17
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,179
-0.44%
|
$363,573
$87.17 P/Share
|
|
Feb 17
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,433
+0.98%
|
-
|
|
Feb 17
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,045
-30.67%
|
$90,915
$87.17 P/Share
|
|
Feb 17
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,358
+40.9%
|
-
|
|
Feb 17
2021
|
Geoffrey M. Curtis EVP, Corporate Affairs, CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-0.8%
|
$60,552
$87.17 P/Share
|
|
Feb 17
2021
|
Geoffrey M. Curtis EVP, Corporate Affairs, CCO |
BUY
Grant, award, or other acquisition
|
Direct |
1,571
+1.77%
|
-
|
|
Feb 17
2021
|
Brian K Beeler EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-0.56%
|
$60,552
$87.17 P/Share
|
|
Feb 17
2021
|
Brian K Beeler EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
1,571
+1.26%
|
-
|
|
Feb 17
2021
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
871
-0.51%
|
$75,777
$87.17 P/Share
|
|
Feb 17
2021
|
Barry Moze EVP, Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+1.13%
|
-
|
|
Feb 17
2021
|
Vikram Karnani EVP & President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
871
-0.77%
|
$75,777
$87.17 P/Share
|
|
Feb 17
2021
|
Vikram Karnani EVP & President, International |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+1.7%
|
-
|
|
Feb 17
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
975
-0.95%
|
$84,825
$87.17 P/Share
|
|
Feb 17
2021
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+1.87%
|
-
|
|
Feb 17
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
871
-1.08%
|
$75,777
$87.17 P/Share
|
|
Feb 17
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+2.37%
|
-
|
|
Feb 17
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-0.79%
|
$60,552
$87.17 P/Share
|
|
Feb 17
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
BUY
Grant, award, or other acquisition
|
Direct |
1,571
+1.75%
|
-
|
|
Feb 17
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,045
-5.56%
|
$90,915
$87.17 P/Share
|
|
Feb 17
2021
|
Andy Pasternak EVP, Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,358
+11.15%
|
-
|
|
Feb 17
2021
|
Jeff Kent Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
696
-0.97%
|
$60,552
$87.17 P/Share
|
|
Feb 17
2021
|
Jeff Kent Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,571
+2.14%
|
-
|
|
Feb 11
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
10,786
-9.63%
|
$970,740
$90.0 P/Share
|
|
Feb 02
2021
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Open market or private sale
|
Direct |
4,530
-3.89%
|
$385,050
$85.0 P/Share
|
|
Feb 01
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Bona fide gift
|
Indirect |
3,094
+1.11%
|
-
|
|
Feb 01
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Bona fide gift
|
Direct |
3,094
-74.68%
|
-
|
|
Feb 01
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
2,950
-12.88%
|
$227,150
$77.04 P/Share
|
|
Feb 01
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
9,087
+28.41%
|
-
|
|
Jan 22
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
11,323
-0.59%
|
$860,548
$76.58 P/Share
|
|
Jan 22
2021
|
Irina Konstantinovsky EVP, Chief Human Resources Off |
SELL
Open market or private sale
|
Direct |
2,226
-2.51%
|
$169,176
$76.81 P/Share
|
|
Jan 22
2021
|
Vikram Karnani EVP & President, International |
SELL
Open market or private sale
|
Direct |
2,731
-2.39%
|
$207,556
$76.81 P/Share
|
|
Jan 21
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Indirect |
755
-5.18%
|
$58,135
$77.43 P/Share
|
|
Jan 21
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,575
+15.03%
|
-
|
|
Jan 21
2021
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,007
-0.93%
|
$693,539
$77.43 P/Share
|
|
Jan 21
2021
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,330
+2.06%
|
-
|
|
Jan 21
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,372
-2.92%
|
$182,644
$77.43 P/Share
|
|
Jan 21
2021
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,353
+6.17%
|
-
|
|
Jan 21
2021
|
Paul W. Hoelscher EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,462
-37.27%
|
$189,574
$77.43 P/Share
|
|
Jan 21
2021
|
Paul W. Hoelscher EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,556
+45.69%
|
-
|
|
Jan 21
2021
|
Jeff Kent Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,349
-1.89%
|
$103,873
$77.43 P/Share
|
|
Jan 21
2021
|
Jeff Kent Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,045
+4.09%
|
-
|
|
Jan 21
2021
|
Barry Moze EVP, Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,578
-1.49%
|
$198,506
$77.43 P/Share
|